On the recordFebruary 3, 2016
In my view, every product that is approved by the FDA should be available to America's seniors and the limiting factor should not be the ability of CMS to stonewall and not pay for it.
Source
congress.govIn my view, every product that is approved by the FDA should be available to America's seniors and the limiting factor should not be the ability of CMS to stonewall and not pay for it.
Bucshon emphasizes that FDA-approved products should be accessible to seniors without CMS delays.
Share
More from Larry Bucshon
I have one additional speaker. Mr. Speaker, I yield 1 minute to the gentleman from Georgia (Mr. Carter).
This amendment will provide clarity that research conducted by the Department of Defense is included in the research registration process outlined in the bill. It also requires the Office of the Inspector General at the Department of…
I strongly support the 340B program, but we certainly need more transparency.
One of my legislative priorities is to increase transparency and accountability in the 340B program.